Steroid receptor coactivator-1 is a histone acetyltransferase-Reference-Cited by-同舟云学术

Steroid receptor coactivator-1 is a histone acetyltransferase

Published:1997-09 Issue:6647 Volume:389 Page:194-198
ISSN:0028-0836
Container-title:Nature
language:en
Short-container-title:Nature

Author:

Spencer Thomas E.,Jenster Guido,Burcin Mark M.,Allis C. David,Zhou Jianxin,Mizzen Craig A.,McKenna Neil J.,Onate Sergio A.,Tsai Sophia Y.,Tsai Ming-Jer,O'Malley Bert W.

Publisher

Springer Science and Business Media LLC

Subject

Multidisciplinary

Link

http://www.nature.com/articles/38304.pdf

Reference26 articles.

1. Klein-Hitpass, L. et al. The progesterone receptor stimulates cell-free transcription by enhancing the formation of a stable preinitiation complex. Cell 60, 247–257 (1990).

2. Brownell, J. E. & Allis, C. D. Special HATs for special occasions: linking histone acetylation to chromatin assembly and gene activation. Curr. Opin. Genet. Dev. 6, 176–184 (1996).

3. Wolffe, A. P. & Pruss, D. Targeting chromatin disruption: transcription regulators that acetylate histones. Cell 86, 817–819 (1996).

4. Wade, P. A. & Wolffe, A. P. Histone acetyltransferases in control. Curr. Biol. 7, R82–R84 (1997).

5. Onate, S. A., Tsai, S. Y., Tsai, M.-J. & O'Malley, B. W. Sequence and characterization of a coactivator for the steroid hormone receptor superfamily. Science 270, 1354–1357 (1995).

Cited by 1149 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Exploring histone deacetylases in type 2 diabetes mellitus: pathophysiological insights and therapeutic avenues;Clinical Epigenetics;2024-06-11

2. Functional Classification of Fusion Proteins in Sarcoma;Cancers;2024-03-29

3. The multifaceted therapeutic value of targeting steroid receptor coactivator-1 in tumorigenesis;Cell & Bioscience;2024-03-29

4. p160 nuclear receptor coactivator family members and their role in rare fusion‑driven neoplasms (Review);Oncology Letters;2024-03-14

5. Epigenetic regulation: Histone modifying enzymes as targets for novel therapeutics;Comprehensive Precision Medicine;2024